Cardiac energetics correlates to myocardial hypertrophy in Friedreich's ataxia
暂无分享,去创建一个
R. Dietz | K. Osterziel | W. Jung | A. Perrot | N. Bit-Avragim | F. Kreuz | M. Bunse | A. Riefflin | O. Schmidt
[1] A. Blamire,et al. Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy: an in vivo 31P magnetic resonance spectroscopy study. , 2001, Cardiovascular research.
[2] H. Watkins,et al. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. , 2001, Human molecular genetics.
[3] J. Melki,et al. Mouse models for Friedreich ataxia exhibit cardiomyopathy, sensory nerve defect and Fe-S enzyme deficiency followed by intramitochondrial iron deposits , 2001, Nature Genetics.
[4] L. Schöls,et al. The GAA repeat expansion in intron 1 of the frataxin gene is related to the severity of cardiac manifestation in patients with Friedreich's ataxia , 2001, Journal of Molecular Medicine.
[5] C. Kahn,et al. Frataxin activates mitochondrial energy conversion and oxidative phosphorylation. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[6] A. Munnich,et al. Effect of idebenone on cardiomyopathy in Friedreich's ataxia: a preliminary study , 1999, The Lancet.
[7] O. Lutz,et al. 31P NMR spectroscopy detects metabolic abnormalities in asymptomatic patients with hypertrophic cardiomyopathy. , 1998, Circulation.
[8] W. Mckenna,et al. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. , 1997, Heart.